Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Grade Serous Adenocarcinoma of Ovary”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04034927
What this trial is testing

Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer

Who this might be right for
Fallopian Tube Endometrioid TumorFallopian Tube High Grade Serous AdenocarcinomaMalignant Ovarian Endometrioid Tumor+11 more
National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)Ended earlyNCT05538624
What this trial is testing

Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

Who this might be right for
Neoplasm, OvarianFallopian Tube CancerPrimary Peritoneal Cavity Cancer+5 more
Avenge Bio, Inc 14
Not applicableEnded earlyNCT03606486
What this trial is testing

Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer

Who this might be right for
High Grade Ovarian Serous AdenocarcinomaStage III Ovarian Cancer AJCC v8Stage IIIA Ovarian Cancer AJCC v8+7 more
University of Washington 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Early research (Phase 1)Ended earlyNCT03924245
What this trial is testing

Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers

Who this might be right for
Fallopian Tube CancerFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+10 more
Vanderbilt-Ingram Cancer Center 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06063070
What this trial is testing

First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer

Who this might be right for
Ovarian CancerHigh Grade Serous Adenocarcinoma of OvaryHigh Grade Endometrioid Ovarian Cancer+2 more
Sun Yat-sen University 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT01116648
What this trial is testing

Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer

Who this might be right for
Fallopian Tube CarcinomaOvarian Endometrioid AdenocarcinomaOvarian High Grade Serous Adenocarcinoma+4 more
National Cancer Institute (NCI) 155
Testing effectiveness (Phase 2)Looking for participantsNCT05961124
What this trial is testing

Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer

Who this might be right for
Ovarian CancerStage III Ovarian CancerStage IV Ovarian Cancer+1 more
Sunnybrook Health Sciences Centre 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05114421
What this trial is testing

Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients

Who this might be right for
High Grade Fallopian Tube Serous AdenocarcinomaHigh Grade Ovarian Serous AdenocarcinomaPeritoneal High Grade Serous Adenocarcinoma+3 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)WithdrawnNCT02756130
What this trial is testing

Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)

Who this might be right for
High Grade Fallopian Tube Serous AdenocarcinomaHigh Grade Ovarian Serous AdenocarcinomaPrimary Peritoneal High Grade Serous Adenocarcinoma+3 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Active Not RecruitingNCT06084416
What this trial is testing

Sovilnesib in Subjects With Ovarian Cancer

Who this might be right for
High Grade Serous Adenocarcinoma of OvaryFallopian Tube CancerPrimary Peritoneal Carcinoma+1 more
Volastra Therapeutics, Inc. 120
Not applicableLooking for participantsNCT04846933
What this trial is testing

Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC

Who this might be right for
High Grade Ovarian Serous AdenocarcinomaHigh Grade Serous Carcinoma
Turku University Hospital 200
Early research (Phase 1)Looking for participantsNCT06451497
What this trial is testing

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

Who this might be right for
Non Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaPancreas Adenocarcinoma+8 more
Zumutor Biologics Inc. 100
Not applicableLooking for participantsNCT06883487
What this trial is testing

Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary

Who this might be right for
Exploring HER2 Positive Diagnostic Criteria in High-grade Serous Ovarian CancerObserving the Effectiveness of Targeted HER2 ADC Drugs
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 144
Testing effectiveness (Phase 2)Looking for participantsNCT05329532
What this trial is testing

Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer

Who this might be right for
Triple Negative Breast CancerRenal Cell CancerHigh Grade Ovarian Serous Adenocarcinoma+1 more
Scancell Ltd 168
Not applicableNot Yet RecruitingNCT06553742
What this trial is testing

High Definition Profiling of Ovarian Cancer Ascites

Who this might be right for
Ovarian CancerHigh Grade Ovarian Serous AdenocarcinomaAscites
European Institute of Oncology 50
Very early researchStudy completedNCT02316834
What this trial is testing

Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Serous AdenocarcinomaHigh Grade Ovarian Serous AdenocarcinomaOvarian Mass+16 more
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT05902988
What this trial is testing

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid TumorHigh Grade Serous Adenocarcinoma of OvarySquamous Non-small-cell Lung Cancer+7 more
Volastra Therapeutics, Inc. 200
Early research (Phase 1)Active Not RecruitingNCT05527184
What this trial is testing

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

Who this might be right for
Endometrial CancerHigh Grade Serous Adenocarcinoma of OvaryPrimary Peritoneal Carcinoma+2 more
AbbVie 256
Not applicableStudy completedNCT04248231
What this trial is testing

CINSARC Genomic Signature as Predictor of Resectability of Ovarian Adenocarcinoma

Who this might be right for
Ovarian Adenocarcinoma
Institut Claudius Regaud 150
Load More Results